SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020467
Filing Date
2024-05-06
Accepted
2024-05-06 08:06:23
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20240331.htm   iXBRL 10-Q 1203167
2 EX-31.1 lyel-20240331x10qxexx311.htm EX-31.1 10646
3 EX-31.2 lyel-20240331x10qxexx312.htm EX-31.2 10616
4 EX-32.1 lyel-20240331x10qxexx321.htm EX-32.1 7489
10 lyel-20240331_g1.jpg GRAPHIC 158306
  Complete submission text file 0001628280-24-020467.txt   6554073

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20240331.xsd EX-101.SCH 42634
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20240331_cal.xml EX-101.CAL 52312
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20240331_def.xml EX-101.DEF 215447
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20240331_lab.xml EX-101.LAB 587956
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20240331_pre.xml EX-101.PRE 411223
69 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20240331_htm.xml XML 755214
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 24915647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)